Cascone Laboratory

Cell Metabolism

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy Opens a new window

Cascone T, McKenzie JA, Mbofung RM, Punt S, Wang Z, Xu C, Williams LJ, Wang Z, Bristow CA, Carugo A, Peoples MD, Li L, Karpinets T, Huang L, Malu S, Creasy C, Leahey SE, Chen J, Chen Y, Pelicano H, Bernatchez C, Gopal YNV, Heffernan TP, Hu J, Wang J, Amaria RN, Garraway LA, Huang P, Yang P, Wistuba II, Woodman SE, Roszik J, Davis RE, Davies MA, Heymach JV, Hwu P, Peng W. (2018).

Nature

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial Opens a new window

Cascone, T., William Jr, W. N., Weissferdt, A., Leung, C. H., Lin, H. Y., Pataer, A., Godoy, M. C. B., Carter, B. W., Federico, L., Reuben, A., Khan, M. A. W., Dejima, H., Francisco-Cruz, A., Parra, E. R., Solis, L. M., Fujimoto, J., Tran, H. T., Kalhor, N., Fossella, F. V., ... Sepesi, B. (2021).

Nature

Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer Opens a new window

Cascone, Tina & Weissferdt, Annikka & Godoy, Myrna & William, William & Leung, Cheuk & Lin, Heather & Basu, Sreyashi & Yadav, Shalini & Pataer, Apar & Mitchell, Kyle & Khan, Md & Shi, Yushu & Haymaker, Cara & Solis, Luisa & Parra, Edwin & Kadara, Humam & Wistuba, Ignacio & Sharma, Praneal & Allison, James & Sepesi, Boris. (2021).